grants awardedPreviously funded grants have included: University of Minnesota - $50,000 (March 2010) Imiquimod/BTIC Lysate-Based Vaccine Immunotherapy for DIPGGrant Information ![]() Thank You Letter
Cincinnati Children’s Hospital Medical Center - $75,000 (March 2010) Telomerase: A Therapeutic Target in Pediatric Brain TumorsGrant Information ![]() Thank You Letter
Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Hospital - $91,740 (March 2010)Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.Grant Information ![]() Website ![]() Thank You Letter
St. Jude Children’s Research Hospital - $50,000 (July, 2009)Phase I Study of the combination of Vandetanib and Dasatanib administered during and after radiation therapy in the children with newly diagnosed DIPG.Grant Information ![]() Website ![]() Thank You Letter
Cincinnati Children’s Hospital Medical Center - $50,000 (July, 2009) National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.Grant Information ![]() Thank You Letter
St. Jude Children’s Research Hospital - $10,000 (July, 2009)
Second phase of genetic analysis of DIPG. |
![]() Check out the Dinner Club to see how you can help The Cure Starts Now simply by eating out. |



Imiquimod/BTIC Lysate-Based Vaccine Immunotherapy for DIPG
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
A multi-institutional study in which an extensive analysis of the genetic make-up of brainstem gliomas will be performed to gain a better understanding of the underlying genetic abnormalities.



